CAR macrophages on a fast track to solid tumor therapy
Crossref DOI link: https://doi.org/10.1038/s41590-023-01696-7
Published Online: 2024-01-02
Published Print: 2024-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Abdin, Shifaa M.
Paasch, Daniela
Lachmann, Nico http://orcid.org/0000-0002-4245-1497
Text and Data Mining valid from 2024-01-01
Version of Record valid from 2024-01-01
Article History
First Online: 2 January 2024
Competing interests
: N.L. declares a patent application on the generation of human iPS cell-derived macrophages (IP PCT/EP2018/061574). The other authors declare no competing interests.